{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T01:05:58Z","timestamp":1768352758862,"version":"3.49.0"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.lfs.2021.119463","type":"journal-article","created":{"date-parts":[[2021,4,18]],"date-time":"2021-04-18T16:34:32Z","timestamp":1618763672000},"page":"119463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Roles of microRNAs in renal disorders related to primary podocyte dysfunction"],"prefix":"10.1016","volume":"277","author":[{"given":"Rahim","family":"Iranzad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roza","family":"Motavalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Ghassabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramin","family":"Pourakbari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jalal","family":"Etemadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2021.119463_bb0005","first-page":"18","article-title":"Identification of genes and miRNAs associated with angiogenesis, metastasis, and apoptosis in colorectal cancer","volume":"100552","author":"Pourakbari","year":"2020","journal-title":"Gene Reports"},{"issue":"8","key":"10.1016\/j.lfs.2021.119463_bb0010","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrm3838","article-title":"Regulation of microRNA biogenesis","volume":"15","author":"Ha","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.lfs.2021.119463_bb0015","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of microRNA biogenesis, mechanisms of actions, and circulation","volume":"9","author":"O\u2019Brien","year":"2018","journal-title":"Front. Endocrinol."},{"issue":"3\u20134","key":"10.1016\/j.lfs.2021.119463_bb0020","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.proghi.2016.06.001","article-title":"Intracellular and extracellular microRNA: an update on localization and biological role","volume":"51","author":"Makarova","year":"2016","journal-title":"Prog. Histochem. Cytochem."},{"issue":"3","key":"10.1016\/j.lfs.2021.119463_bb0025","doi-asserted-by":"crossref","first-page":"5519","DOI":"10.3390\/ijms14035519","article-title":"MicroRNAs in human placental development and pregnancy complications","volume":"14","author":"Fu","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2021.119463_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.mgene.2020.100750","article-title":"Association between interleukin 2 receptor A gene polymorphisms (rs2104286 and rs12722489) with susceptibility to multiple sclerosis in Iranian population","volume":"25","author":"Pourakbari","year":"2020","journal-title":"Meta Gene"},{"key":"10.1016\/j.lfs.2021.119463_bb0035","series-title":"Bioinformatics in MicroRNA Research","first-page":"57","article-title":"MicroRNAs: biomarkers, diagnostics, and therapeutics","author":"Huang","year":"2017"},{"issue":"1","key":"10.1016\/j.lfs.2021.119463_bb0040","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/jcp.25056","article-title":"MicroRNA as biomarkers and diagnostics","volume":"231","author":"Wang","year":"2016","journal-title":"J. Cell. Physiol."},{"issue":"15","key":"10.1016\/j.lfs.2021.119463_bb0045","doi-asserted-by":"crossref","first-page":"12837","DOI":"10.18632\/oncotarget.3805","article-title":"miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies","volume":"6","author":"Amodio","year":"2015","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.lfs.2021.119463_bb0050","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00467-014-2867-7","article-title":"MicroRNAs and their applications in kidney diseases","volume":"30","author":"Badal","year":"2015","journal-title":"Pediatr. Nephrol."},{"issue":"1","key":"10.1016\/j.lfs.2021.119463_bb0055","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1293\/tox.2017-0051","article-title":"MicroRNAs associated with the development of kidney diseases in humans and animals","volume":"31","author":"Ichii","year":"2018","journal-title":"J. Toxicol. Pathol."},{"issue":"2","key":"10.1016\/j.lfs.2021.119463_bb0060","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/01.ASN.0000108969.21691.5D","article-title":"The classification of glomerulonephritis in systemic lupus erythematosus revisited","volume":"15","author":"Weening","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"issue":"12","key":"10.1016\/j.lfs.2021.119463_bb0065","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/sj.ki.5002222","article-title":"The spectrum of podocytopathies: a unifying view of glomerular diseases","volume":"71","author":"Wiggins","year":"2007","journal-title":"Kidney Int."},{"issue":"8","key":"10.1016\/j.lfs.2021.119463_bb0070","doi-asserted-by":"crossref","first-page":"698","DOI":"10.2174\/156652408786733739","article-title":"MicroRNAs in organogenesis and disease","volume":"8","author":"Asli","year":"2008","journal-title":"Curr. Mol. Med."},{"issue":"2","key":"10.1016\/j.lfs.2021.119463_bb0075","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nrm2632","article-title":"Biogenesis of small RNAs in animals","volume":"10","author":"Kim","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"24","key":"10.1016\/j.lfs.2021.119463_bb0080","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1101\/gad.1158803","article-title":"Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs","volume":"17","author":"Yi","year":"2003","journal-title":"Genes Dev."},{"issue":"1","key":"10.1016\/j.lfs.2021.119463_bb0085","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cell.2004.06.017","article-title":"Single processing center models for human Dicer and bacterial RNase III","volume":"118","author":"Zhang","year":"2004","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.lfs.2021.119463_bb0090","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.molcel.2004.07.007","article-title":"Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs","volume":"15","author":"Meister","year":"2004","journal-title":"Mol. Cell"},{"issue":"5","key":"10.1016\/j.lfs.2021.119463_bb0095","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/ng2003","article-title":"Impaired microRNA processing enhances cellular transformation and tumorigenesis","volume":"39","author":"Kumar","year":"2007","journal-title":"Nat. Genet."},{"issue":"42","key":"10.1016\/j.lfs.2021.119463_bb0100","doi-asserted-by":"crossref","first-page":"16230","DOI":"10.1073\/pnas.0808830105","article-title":"MicroRNA-directed transcriptional gene silencing in mammalian cells","volume":"105","author":"Kim","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.lfs.2021.119463_bb0105","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1146\/annurev-biochem-060308-103103","article-title":"Regulation of mRNA translation and stability by microRNAs","volume":"79","author":"Fabian","year":"2010","journal-title":"Annu. Rev. Biochem."},{"issue":"5808","key":"10.1016\/j.lfs.2021.119463_bb0110","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1126\/science.1136235","article-title":"A hexanucleotide element directs microRNA nuclear import","volume":"315","author":"Hwang","year":"2007","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.lfs.2021.119463_bb0115","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s13238-013-3001-5","article-title":"Nuclear microRNAs and their unconventional role in regulating non-coding RNAs","volume":"4","author":"Liang","year":"2013","journal-title":"Protein Cell"},{"issue":"3","key":"10.1016\/j.lfs.2021.119463_bb0120","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1373\/clinchem.2007.097972","article-title":"Detection and characterization of placental microRNAs in maternal plasma","volume":"54","author":"Chim","year":"2008","journal-title":"Clin. Chem."},{"issue":"6","key":"10.1016\/j.lfs.2021.119463_bb0125","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1596","article-title":"Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells","volume":"9","author":"Valadi","year":"2007","journal-title":"Nat. Cell Biol."},{"issue":"6","key":"10.1016\/j.lfs.2021.119463_bb0130","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1007\/s11033-010-0535-y","article-title":"Identification of the transcriptional promoters in the proximal regions of human microRNA genes","volume":"38","author":"Long","year":"2011","journal-title":"Mol. Biol. Rep."},{"issue":"3","key":"10.1016\/j.lfs.2021.119463_bb0135","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1261\/rna.1731910","article-title":"Structure and activity of putative intronic miRNA promoters","volume":"16","author":"Monteys","year":"2010","journal-title":"Rna"},{"issue":"20","key":"10.1016\/j.lfs.2021.119463_bb0140","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1038\/sj.emboj.7600385","article-title":"MicroRNA genes are transcribed by RNA polymerase II","volume":"23","author":"Lee","year":"2004","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.lfs.2021.119463_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4161\/epi.3.1.5651","article-title":"Oncoproteins, heterochromatin silencing and microRNAs: a new link for leukemogenesis","volume":"3","author":"Nervi","year":"2008","journal-title":"Epigenetics"},{"issue":"3","key":"10.1016\/j.lfs.2021.119463_bb0150","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/ncb0309-228","article-title":"Many roads to maturity: microRNA biogenesis pathways and their regulation","volume":"11","author":"Winter","year":"2009","journal-title":"Nat. Cell Biol."},{"issue":"2","key":"10.1016\/j.lfs.2021.119463_bb0155","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.molcel.2008.09.014","article-title":"Lin28 mediates the terminal uridylation of let-7 precursor MicroRNA","volume":"32","author":"Heo","year":"2008","journal-title":"Mol. Cell"},{"issue":"6","key":"10.1016\/j.lfs.2021.119463_bb0160","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1093\/nar\/gkp031","article-title":"Adenylation of plant miRNAs","volume":"37","author":"Lu","year":"2009","journal-title":"Nucleic Acids Res."},{"issue":"16","key":"10.1016\/j.lfs.2021.119463_bb0165","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.cub.2005.07.029","article-title":"Methylation protects miRNAs and siRNAs from a 3\u2032-end uridylation activity in Arabidopsis","volume":"15","author":"Li","year":"2005","journal-title":"Curr. Biol."},{"issue":"6","key":"10.1016\/j.lfs.2021.119463_bb0170","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.kint.2016.01.012","article-title":"Podocyte injury and its consequences","volume":"89","author":"Nagata","year":"2016","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.lfs.2021.119463_bb0175","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000481633","article-title":"A review of podocyte biology","volume":"47","author":"Garg","year":"2018","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.lfs.2021.119463_bb0180","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev-med-050311-163340","article-title":"Podocyte biology and pathogenesis of kidney disease","volume":"64","author":"Reiser","year":"2013","journal-title":"Annu. Rev. Med."},{"issue":"6","key":"10.1016\/j.lfs.2021.119463_bb0185","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1681\/ASN.2017010027","article-title":"New insights into podocyte biology in glomerular health and disease","volume":"28","author":"Assady","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.lfs.2021.119463_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5527\/wjn.v2.i1.1","article-title":"Roles of adaptor proteins in podocyte biology","volume":"2","author":"Ha","year":"2013","journal-title":"World journal of nephrology"},{"issue":"11","key":"10.1016\/j.lfs.2021.119463_bb0195","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1681\/ASN.2008020162","article-title":"Podocyte-specific loss of functional microRNAs leads to rapid glomerular and tubular injury","volume":"19","author":"Ho","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.lfs.2021.119463_bb0200","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/ki.2011.122","article-title":"The inducible deletion of Drosha and microRNAs in mature podocytes results in a collapsing glomerulopathy","volume":"80","author":"Zhdanova","year":"2011","journal-title":"Kidney Int."},{"issue":"12","key":"10.1016\/j.lfs.2021.119463_bb0205","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1681\/ASN.2012030321","article-title":"MicroRNAs regulate renal tubule maturation through modulation of Pkd1","volume":"23","author":"Patel","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.lfs.2021.119463_bb0210","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1681\/ASN.2009090964","article-title":"The microRNA-processing enzyme dicer maintains juxtaglomerular cells","volume":"21","author":"Sequeira-Lopez","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.lfs.2021.119463_bb0215","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1681\/ASN.2009070718","article-title":"Targeted deletion of Dicer from proximal tubules protects against renal ischemia-reperfusion injury","volume":"21","author":"Wei","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.lfs.2021.119463_bb0220","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/920134","article-title":"The role of microRNAs in diabetic nephropathy","volume":"2014","author":"Wu","year":"2014","journal-title":"J. Diabetes Res."},{"issue":"11","key":"10.1016\/j.lfs.2021.119463_bb0225","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1681\/ASN.2008020162","article-title":"Podocyte-specific loss of functional microRNAs leads to rapid glomerular and tubular injury","volume":"19","author":"Ho","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"issue":"23","key":"10.1016\/j.lfs.2021.119463_bb0230","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1242\/dev.037432","article-title":"The miR-30 miRNA family regulates Xenopus pronephros development and targets the transcription factor Xlim1\/Lhx1","volume":"136","author":"Agrawal","year":"2009","journal-title":"Development"},{"issue":"4","key":"10.1016\/j.lfs.2021.119463_bb0235","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nm.3142","article-title":"Focal segmental glomerulosclerosis is induced by microRNA-193a and its downregulation of WT1","volume":"19","author":"Gebeshuber","year":"2013","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.lfs.2021.119463_bb0240","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/1470320312460071","article-title":"Changes in microRNAs associated with podocytic adhesion damage under mechanical stress","volume":"14","author":"Li","year":"2013","journal-title":"J. Renin-Angiotensin-Aldosterone Syst."},{"issue":"6","key":"10.1016\/j.lfs.2021.119463_bb0245","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1172\/JCI200112367","article-title":"Apoptosis in podocytes induced by TGF-\u03b2 and Smad7","volume":"108","author":"Schiffer","year":"2001","journal-title":"J. Clin. Invest."},{"issue":"13","key":"10.1016\/j.lfs.2021.119463_bb0250","doi-asserted-by":"crossref","first-page":"11837","DOI":"10.1074\/jbc.M110.194969","article-title":"MicroRNA-29c is a signature microRNA under high glucose conditions that targets Sprouty homolog 1, and its in vivo knockdown prevents progression of diabetic nephropathy","volume":"286","author":"Long","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.lfs.2021.119463_bb0255","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1159\/000333809","article-title":"MicroRNA-195 promotes apoptosis in mouse podocytes via enhanced caspase activity driven by BCL2 insufficiency","volume":"34","author":"Chen","year":"2011","journal-title":"Am. J. Nephrol."},{"issue":"2","key":"10.1016\/j.lfs.2021.119463_bb0260","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2215\/CJN.05000516","article-title":"Minimal change disease","volume":"12","author":"Vivarelli","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.lfs.2021.119463_bb0265","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1681\/ASN.2012070734","article-title":"The treatment of minimal change disease in adults","volume":"24","author":"Hogan","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.lfs.2021.119463_bb0270","first-page":"5","article-title":"Cell biology and genetics of minimal change disease","author":"Saleem","year":"2016","journal-title":"F1000Research"},{"issue":"10","key":"10.1016\/j.lfs.2021.119463_bb0275","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1093\/ndt\/gfw021","article-title":"Targeting the podocyte cytoskeleton: from pathogenesis to therapy in proteinuric kidney disease","volume":"31","author":"Tian","year":"2016","journal-title":"Nephrol. Dial. Transplant."},{"issue":"1","key":"10.1016\/j.lfs.2021.119463_bb0280","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/ndt\/gfq617","article-title":"The podocyte as a direct target of immunosuppressive agents","volume":"26","author":"Sch\u00f6nenberger","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"issue":"11","key":"10.1016\/j.lfs.2021.119463_bb0285","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1097\/01.smj.0000243183.87381.c2","article-title":"Minimal change disease: a review","volume":"99","author":"Saha","year":"2006","journal-title":"South. Med. J."},{"issue":"2","key":"10.1016\/j.lfs.2021.119463_bb0290","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000486967","article-title":"miR-499 ameliorates podocyte injury by targeting calcineurin in minimal change disease","volume":"47","author":"Zhang","year":"2018","journal-title":"Am. J. Nephrol."},{"issue":"5","key":"10.1016\/j.lfs.2021.119463_bb0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155504","article-title":"Calpain-mediated cleavage of calcineurin in puromycin aminonucleoside-induced podocyte injury","volume":"11","author":"Ding","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.lfs.2021.119463_bb0300","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2215\/CJN.05960616","article-title":"Focal Segmental Glomerulosclerosis","volume":"12","author":"Rosenberg","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.lfs.2021.119463_bb0305","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1053\/j.ajkd.2003.10.024","article-title":"Pathologic classification of focal segmental glomerulosclerosis: a working proposal","volume":"43","author":"D\u2019Agati","year":"2004","journal-title":"Am. J. Kidney Dis."},{"issue":"6","key":"10.1016\/j.lfs.2021.119463_bb0310","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0272-6386(12)80128-4","article-title":"Primary focal segmental glomerulosclerosis: clinical course and response to therapy","volume":"23","author":"Korbet","year":"1994","journal-title":"Am. J. Kidney Dis."},{"issue":"1 Suppl 1","key":"10.1016\/j.lfs.2021.119463_bb0315","doi-asserted-by":"crossref","first-page":"A8","DOI":"10.1053\/j.ajkd.2010.10.007","article-title":"US Renal Data System 2010 Annual Data Report","volume":"57","author":"Collins","year":"2011","journal-title":"Am. J. Kidney Dis."},{"issue":"3","key":"10.1016\/j.lfs.2021.119463_bb0320","doi-asserted-by":"crossref","first-page":"414","DOI":"10.2215\/CJN.04780517","article-title":"An outcomes-based definition of proteinuria remission in focal segmental glomerulosclerosis","volume":"13","author":"Troost","year":"2018","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.lfs.2021.119463_bb0325","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nm.3142","article-title":"Focal segmental glomerulosclerosis is induced by microRNA-193a and its downregulation of WT1","volume":"19","author":"Gebeshuber","year":"2013","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.lfs.2021.119463_bb0330","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000167173","article-title":"Recurrent focal segmental glomerulosclerosis. A pathological study of the early lesion","volume":"6","author":"Verani","year":"1986","journal-title":"Am. J. Nephrol."},{"issue":"11","key":"10.1016\/j.lfs.2021.119463_bb0335","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1681\/ASN.2008030312","article-title":"Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis","volume":"19","author":"Shi","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.lfs.2021.119463_bb0340","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/eci.12420","article-title":"Circulating and urinary micro RNA profile in focal segmental glomerulosclerosis: a pilot study","volume":"45","author":"Ramezani","year":"2015","journal-title":"Eur. J. Clin. Investig."},{"issue":"9","key":"10.1016\/j.lfs.2021.119463_bb0345","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.2215\/CJN.11561113","article-title":"Evaluation of microRNAs miR-196a, miR-30a-5P, and miR-490 as biomarkers of disease activity among patients with FSGS","volume":"9","author":"Zhang","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.lfs.2021.119463_bb0350","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1053\/j.ajkd.2014.07.013","article-title":"Plasma microRNA-186 and proteinuria in focal segmental glomerulosclerosis","volume":"65","author":"Zhang","year":"2015","journal-title":"Am. J. Kidney Dis."},{"issue":"9","key":"10.1016\/j.lfs.2021.119463_bb0355","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1007\/s00467-013-2434-7","article-title":"Serum microRNAs levels in primary focal segmental glomerulosclerosis","volume":"28","author":"Cai","year":"2013","journal-title":"Pediatric nephrology (Berlin, Germany)"},{"issue":"5","key":"10.1016\/j.lfs.2021.119463_bb0360","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-018-0569-y","article-title":"Plasma microRNA panel is a novel biomarker for focal segmental glomerulosclerosis and associated with podocyte apoptosis","volume":"9","author":"Xiao","year":"2018","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.lfs.2021.119463_bb0365","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1007\/s00467-013-2434-7","article-title":"Serum microRNAs levels in primary focal segmental glomerulosclerosis","volume":"28","author":"Cai","year":"2013","journal-title":"Pediatr. Nephrol."},{"issue":"5","key":"10.1016\/j.lfs.2021.119463_bb0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-018-0569-y","article-title":"Plasma microRNA panel is a novel biomarker for focal segmental glomerulosclerosis and associated with podocyte apoptosis","volume":"9","author":"Xiao","year":"2018","journal-title":"Cell Death Dis."},{"issue":"12","key":"10.1016\/j.lfs.2021.119463_bb0375","doi-asserted-by":"crossref","first-page":"e51140","DOI":"10.1371\/journal.pone.0051140","article-title":"Urinary microRNA-10a and microRNA-30d serve as novel, sensitive and specific biomarkers for kidney injury","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.lfs.2021.119463_bb0380","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1681\/ASN.2012111101","article-title":"Downregulation of microRNA-30 facilitates podocyte injury and is prevented by glucocorticoids","volume":"25","author":"Wu","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.lfs.2021.119463_bb0385","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3892\/ijmm.2015.2259","article-title":"miR-135 family members mediate podocyte injury through the activation of Wnt\/\u03b2-catenin signaling","volume":"36","author":"Yang","year":"2015","journal-title":"Int. J. Mol. Med."},{"issue":"2","key":"10.1016\/j.lfs.2021.119463_bb0390","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1053\/j.ajkd.2014.07.013","article-title":"Plasma microRNA-186 and proteinuria in focal segmental glomerulosclerosis","volume":"65","author":"Zhang","year":"2015","journal-title":"Am. J. Kidney Dis."},{"issue":"9","key":"10.1016\/j.lfs.2021.119463_bb0395","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.2215\/CJN.11561113","article-title":"Evaluation of microRNAs miR-196a, miR-30a-5P, and miR-490 as biomarkers of disease activity among patients with FSGS","volume":"9","author":"Zhang","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"6","key":"10.1016\/j.lfs.2021.119463_bb0400","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2215\/CJN.11761116","article-title":"Primary membranous nephropathy","volume":"12","author":"Couser","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.lfs.2021.119463_bb0405","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.archger.2018.03.002","article-title":"Treatment and clinical outcomes of elderly idiopathic membranous nephropathy: a multicenter cohort study in Korea","volume":"76","author":"Bae","year":"2018","journal-title":"Arch. Gerontol. Geriatr."},{"issue":"6","key":"10.1016\/j.lfs.2021.119463_bb0410","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000506948","article-title":"New ways of understanding membranous nephropathy","volume":"144","author":"Trujillo","year":"2020","journal-title":"Nephron"},{"issue":"Suppl. 1","key":"10.1016\/j.lfs.2021.119463_bb0415","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000481635","article-title":"Membranous nephropathy: approaches to treatment","volume":"47","author":"Bomback","year":"2018","journal-title":"Am. J. Nephrol."},{"issue":"3","key":"10.1016\/j.lfs.2021.119463_bb0420","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.kint.2016.09.048","article-title":"Membranous nephropathy: integrating basic science into improved clinical management","volume":"91","author":"Cattran","year":"2017","journal-title":"Kidney Int."},{"key":"10.1016\/j.lfs.2021.119463_bb0425","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3389\/fimmu.2020.00837","article-title":"Phospholipase A2 receptor autoantibodies as a novel serological biomarker for autoimmune thyroid disease associated nephropathy","volume":"11","author":"Huang","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.lfs.2021.119463_bb0430","doi-asserted-by":"crossref","DOI":"10.3390\/biom10020319","article-title":"Role of serum and urine biomarkers (PLA(2)R and THSD7A) in diagnosis, monitoring and prognostication of primary membranous glomerulonephritis","volume":"10","author":"Maifata","year":"2020","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.lfs.2021.119463_bb0435","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00281-014-0423-y","article-title":"Immunopathogenesis of membranous nephropathy: an update","volume":"36","author":"Debiec","year":"2014","journal-title":"Semin. Immunopathol."},{"issue":"3","key":"10.1016\/j.lfs.2021.119463_bb0440","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/nep.13833","article-title":"Bioinformatic investigation for candidate genes and molecular mechanism in the pathogenesis of membranous nephropathy","volume":"26","author":"Li","year":"2020","journal-title":"Nephrology (Carlton, Vic)"},{"key":"10.1016\/j.lfs.2021.119463_bb0445","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000486943","article-title":"Direct effects of immunomodulatory agents on podocytes in immune-mediated glomerular diseases","volume":"195","author":"Manabe","year":"2018","journal-title":"Contrib. Nephrol."},{"key":"10.1016\/j.lfs.2021.119463_bb0450","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3389\/fimmu.2016.00157","article-title":"Alternative pathway dysregulation and the conundrum of complement activation by IgG4 immune complexes in membranous nephropathy","volume":"7","author":"Borza","year":"2016","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.lfs.2021.119463_bb0455","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1681\/ASN.2005010087","article-title":"Membranous nephropathy: a long road but well traveled","volume":"16","author":"Couser","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.lfs.2021.119463_bb0460","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3892\/ijmm.2013.1554","article-title":"Integrated profiling of microRNA expression in membranous nephropathy using high-throughput sequencing technology","volume":"33","author":"Chen","year":"2014","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.lfs.2021.119463_bb0465","first-page":"2017","article-title":"miR-217 is a useful diagnostic biomarker and regulates human podocyte cells apoptosis via targeting TNFSF11 in membranous nephropathy","volume":"2168767","author":"Li","year":"2017","journal-title":"Biomed. Res. Int."},{"issue":"8","key":"10.1016\/j.lfs.2021.119463_bb0470","doi-asserted-by":"crossref","first-page":"12625","DOI":"10.1002\/jcp.27851","article-title":"Upregulated microRNAs in membranous glomerulonephropathy are associated with significant downregulation of IL6 and MYC mRNAs","volume":"234","author":"Barbagallo","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.lfs.2021.119463_bb0475","first-page":"e13414","article-title":"Circ_0000524\/miR-500a-5p\/CXCL16 axis promotes podocyte apoptosis in membranous nephropathy","author":"Sun","year":"2020","journal-title":"Eur. J. Clin. Investig."},{"issue":"8","key":"10.1016\/j.lfs.2021.119463_bb0480","doi-asserted-by":"crossref","first-page":"12625","DOI":"10.1002\/jcp.27851","article-title":"Upregulated microRNAs in membranous glomerulonephropathy are associated with significant downregulation of IL6 and MYC mRNAs","volume":"234","author":"Barbagallo","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.lfs.2021.119463_bb0485","first-page":"e13414","article-title":"Circ_0000524\/miR-500a-5p\/CXCL16 axis promotes podocyte apoptosis in membranous nephropathy","author":"Sun","year":"2020","journal-title":"Eur. J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.lfs.2021.119463_bb0490","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3892\/ijmm.2013.1554","article-title":"Integrated profiling of microRNA expression in membranous nephropathy using high-throughput sequencing technology","volume":"33","author":"Chen","year":"2014","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.lfs.2021.119463_bb0495","first-page":"2017","article-title":"miR-217 is a useful diagnostic biomarker and regulates human podocyte cells apoptosis via targeting tnfsf11 in membranous nephropathy","author":"Li","year":"2017","journal-title":"Biomed. Res. Int."},{"issue":"9","key":"10.1016\/j.lfs.2021.119463_bb0500","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s00467-011-1785-1","article-title":"Glomerular basement membrane composition and the filtration barrier","volume":"26","author":"Miner","year":"2011","journal-title":"Pediatric nephrology (Berlin, Germany)"},{"key":"10.1016\/j.lfs.2021.119463_bb0505","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.matbio.2018.04.008","article-title":"Alport syndrome and Pierson syndrome: diseases of the glomerular basement membrane","volume":"71-72","author":"Funk","year":"2018","journal-title":"Matrix Biol."},{"issue":"7","key":"10.1016\/j.lfs.2021.119463_bb0510","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1089\/hum.2018.205","article-title":"Dysregulated expression of microRNA-21 and disease-related genes in human patients and in a mouse model of Alport syndrome","volume":"30","author":"Guo","year":"2019","journal-title":"Hum. Gene Ther."},{"issue":"4","key":"10.1016\/j.lfs.2021.119463_bb0515","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10565-016-9335-z","article-title":"Identification of a microRNA (miR-663a) induced by ER stress and its target gene PLOD3 by a combined microRNome and proteome approach","volume":"32","author":"Amodio","year":"2016","journal-title":"Cell Biol. Toxicol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521004483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521004483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:50:45Z","timestamp":1758401445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320521004483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":103,"alternative-id":["S0024320521004483"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2021.119463","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Roles of microRNAs in renal disorders related to primary podocyte dysfunction","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2021.119463","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"119463"}}